APA (7th ed.) Citation

XY, P., SYY, M., AYY, Y., JM, C., DRX, L., CCY, T., . . . BE, Y. (2026). NVX-CoV2372, monovalent mRNA and bivalent mRNA vaccines elicit broadly cross-reactive antibodies against emerging SARS-CoV-2 variants. Human vaccines & immunotherapeutics, 22(1), 2638022. https://doi.org/10.1080/21645515.2026.2638022

Chicago Style (17th ed.) Citation

XY, Poh, et al. "NVX-CoV2372, Monovalent MRNA and Bivalent MRNA Vaccines Elicit Broadly Cross-reactive Antibodies Against Emerging SARS-CoV-2 Variants." Human Vaccines & Immunotherapeutics 22, no. 1 (2026): 2638022. https://doi.org/10.1080/21645515.2026.2638022.

MLA (9th ed.) Citation

XY, Poh, et al. "NVX-CoV2372, Monovalent MRNA and Bivalent MRNA Vaccines Elicit Broadly Cross-reactive Antibodies Against Emerging SARS-CoV-2 Variants." Human Vaccines & Immunotherapeutics, vol. 22, no. 1, 2026, p. 2638022, https://doi.org/10.1080/21645515.2026.2638022.